4 completed. 2 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Fluzone® High-Dose: new trials by email Literature Review of Fluzone® High-Dose trials Research Report on Fluzone® High-Dose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FLUAD® vs. Fluzone® High-Dose Study FLUAD®, Fluzone® High-Dose - Pain, Quality of Life | Phase 4 | Completed | Duke University | 757 | 2017-08-28 | 2021-03-30 |
| A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age High-Dose Trivalent Inactivated Influenza Vaccine, Trivalent Inactivated Influenza Vaccine - Influenza | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 300 | 2010-11-01 | 2016-05-16 |
| Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects Split, Inactivated, Trivalent Influenza Vaccine (Intradermal Formulation 1), Split, Inactivated, Trivalent Influenza Vaccine (Intradermal Formulation 2), Split, Inactivated, Trivalent Influenza Vaccine (Standard dose) - Influenza, Myxovirus Infection | Phase 2 | Completed | Sanofi | 2098 | 2007-10-01 | 2016-05-16 |
| Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly High-Dose Inactivated, Split-Virion Influenza Vaccine, Inactivated, Split-Virion Influenza Vaccine - Orthomyxoviridae Infection, Influenza | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 3851 | 2006-10-01 | 2016-04-14 |
Influenza, Human (4) · Drug-Related Side Effects and Adverse Reactions (1) · Injection Site Reaction (1) · Orthomyxoviridae Infections (1) · Pain (1)
Sanofi Pasteur, a Sanofi Company (2) · Duke University (1) · Sanofi (1)
United States (4)
Elizabeth Barnett, MD (1) · Kenneth Schmader, MD (1) · Theresa Harrington, MD (1)